Features: * A convenient, authoritative, up-to-date guide for every clinician who treats patients with malignant disease * Covers every anticancer drug commonly used in Europe and the United States * Provides instant access to the latest clinical findings on anticancer drugs and their use in the management of adult and paediatric cancer patients * Also includes new advances in combined modality therapy and immunotherapy, as well as new anticancer drugs now being tested in laboratories around the world * Stephen K. Carter is Vice President, Anticancer Research, Bristol Myers Company, New York, New York, USA, Marie T. Bakowski is Director, Clinical Studies, Boehringer Ingelheim Limited, Bracknell, Berkshire, UK, Kurt Hellmann is Honorary Professor and Consultant, Radiotherapy and Oncology Department, Westminster Hospital, London, UK